The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.

Kinya Matsuoka, Kazunori Tsukuda, Manabu Suda, Kazuyasu Kobayashi, Tetsuya Ota, Atsushi Okita, Keitaro Watanabe, Eiji Suzuki, Masakazu Murakami, Hiroyoshi Doihara, Nobuyoshi Shimizu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

5-Fluorouracil (5-FU), a fluoropyrimidine analogue, is one of the most commonly used anticancer drugs for the treatment of gastrointestinal malignancies. Some studies reported that the cytotoxicity of fluoropyrimidines is mediated, in large part, by inhibition of the thymidylate synthase (TS), an essential DNA synthetic enzyme. The aim of this study was to determine if antisense TS technology could augment the chemosensitivity of human cancer cells to 5-FU. The full length coding region of TS cDNA was inversely cloned into the eukaryotic expression vector pCDL81 and transfected into DLD-1 cells. The expression and activity of TS were significantly suppressed in the antisense TS transfected cells. Interestingly, the transfection of antisense TS alone inhibited the cellular growth in vitro. The chemosensitivity to 5-FU was significantly increased in the transfected cells. The 50% inhibition values of 5-FU on DLD-1/anti-TS were approximately one forth that on parental cells. The augmentation of chemosensitivity to 5-FU was also confirmed in a nude mice model. The tumor growth of DLD-1/anti-TS cells was suppressed significantly more than that of DLD-1 cells by the 5-FU. The expression and activity of TS in human colon cancer cells were effectively inhibited by TS antisense treatment and the effect of 5-FU to cancer cells can be augmented. The antisense TS technology could be promising for treatments of gastrointestinal cancers.

Original languageEnglish
Pages (from-to)217-222
Number of pages6
JournalInternational Journal of Oncology
Volume24
Issue number1
Publication statusPublished - Jan 2004
Externally publishedYes

Fingerprint

Thymidylate Synthase
Fluorouracil
Colonic Neoplasms
Transfection
Cell Line
Neoplasms
Technology
Gastrointestinal Agents
Gastrointestinal Neoplasms
Growth
Nude Mice
Complementary DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil. / Matsuoka, Kinya; Tsukuda, Kazunori; Suda, Manabu; Kobayashi, Kazuyasu; Ota, Tetsuya; Okita, Atsushi; Watanabe, Keitaro; Suzuki, Eiji; Murakami, Masakazu; Doihara, Hiroyoshi; Shimizu, Nobuyoshi.

In: International Journal of Oncology, Vol. 24, No. 1, 01.2004, p. 217-222.

Research output: Contribution to journalArticle

Matsuoka, K, Tsukuda, K, Suda, M, Kobayashi, K, Ota, T, Okita, A, Watanabe, K, Suzuki, E, Murakami, M, Doihara, H & Shimizu, N 2004, 'The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.', International Journal of Oncology, vol. 24, no. 1, pp. 217-222.
Matsuoka, Kinya ; Tsukuda, Kazunori ; Suda, Manabu ; Kobayashi, Kazuyasu ; Ota, Tetsuya ; Okita, Atsushi ; Watanabe, Keitaro ; Suzuki, Eiji ; Murakami, Masakazu ; Doihara, Hiroyoshi ; Shimizu, Nobuyoshi. / The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil. In: International Journal of Oncology. 2004 ; Vol. 24, No. 1. pp. 217-222.
@article{4e05eb7bf7cc4529bc39f43cad3805e5,
title = "The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.",
abstract = "5-Fluorouracil (5-FU), a fluoropyrimidine analogue, is one of the most commonly used anticancer drugs for the treatment of gastrointestinal malignancies. Some studies reported that the cytotoxicity of fluoropyrimidines is mediated, in large part, by inhibition of the thymidylate synthase (TS), an essential DNA synthetic enzyme. The aim of this study was to determine if antisense TS technology could augment the chemosensitivity of human cancer cells to 5-FU. The full length coding region of TS cDNA was inversely cloned into the eukaryotic expression vector pCDL81 and transfected into DLD-1 cells. The expression and activity of TS were significantly suppressed in the antisense TS transfected cells. Interestingly, the transfection of antisense TS alone inhibited the cellular growth in vitro. The chemosensitivity to 5-FU was significantly increased in the transfected cells. The 50{\%} inhibition values of 5-FU on DLD-1/anti-TS were approximately one forth that on parental cells. The augmentation of chemosensitivity to 5-FU was also confirmed in a nude mice model. The tumor growth of DLD-1/anti-TS cells was suppressed significantly more than that of DLD-1 cells by the 5-FU. The expression and activity of TS in human colon cancer cells were effectively inhibited by TS antisense treatment and the effect of 5-FU to cancer cells can be augmented. The antisense TS technology could be promising for treatments of gastrointestinal cancers.",
author = "Kinya Matsuoka and Kazunori Tsukuda and Manabu Suda and Kazuyasu Kobayashi and Tetsuya Ota and Atsushi Okita and Keitaro Watanabe and Eiji Suzuki and Masakazu Murakami and Hiroyoshi Doihara and Nobuyoshi Shimizu",
year = "2004",
month = "1",
language = "English",
volume = "24",
pages = "217--222",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.

AU - Matsuoka, Kinya

AU - Tsukuda, Kazunori

AU - Suda, Manabu

AU - Kobayashi, Kazuyasu

AU - Ota, Tetsuya

AU - Okita, Atsushi

AU - Watanabe, Keitaro

AU - Suzuki, Eiji

AU - Murakami, Masakazu

AU - Doihara, Hiroyoshi

AU - Shimizu, Nobuyoshi

PY - 2004/1

Y1 - 2004/1

N2 - 5-Fluorouracil (5-FU), a fluoropyrimidine analogue, is one of the most commonly used anticancer drugs for the treatment of gastrointestinal malignancies. Some studies reported that the cytotoxicity of fluoropyrimidines is mediated, in large part, by inhibition of the thymidylate synthase (TS), an essential DNA synthetic enzyme. The aim of this study was to determine if antisense TS technology could augment the chemosensitivity of human cancer cells to 5-FU. The full length coding region of TS cDNA was inversely cloned into the eukaryotic expression vector pCDL81 and transfected into DLD-1 cells. The expression and activity of TS were significantly suppressed in the antisense TS transfected cells. Interestingly, the transfection of antisense TS alone inhibited the cellular growth in vitro. The chemosensitivity to 5-FU was significantly increased in the transfected cells. The 50% inhibition values of 5-FU on DLD-1/anti-TS were approximately one forth that on parental cells. The augmentation of chemosensitivity to 5-FU was also confirmed in a nude mice model. The tumor growth of DLD-1/anti-TS cells was suppressed significantly more than that of DLD-1 cells by the 5-FU. The expression and activity of TS in human colon cancer cells were effectively inhibited by TS antisense treatment and the effect of 5-FU to cancer cells can be augmented. The antisense TS technology could be promising for treatments of gastrointestinal cancers.

AB - 5-Fluorouracil (5-FU), a fluoropyrimidine analogue, is one of the most commonly used anticancer drugs for the treatment of gastrointestinal malignancies. Some studies reported that the cytotoxicity of fluoropyrimidines is mediated, in large part, by inhibition of the thymidylate synthase (TS), an essential DNA synthetic enzyme. The aim of this study was to determine if antisense TS technology could augment the chemosensitivity of human cancer cells to 5-FU. The full length coding region of TS cDNA was inversely cloned into the eukaryotic expression vector pCDL81 and transfected into DLD-1 cells. The expression and activity of TS were significantly suppressed in the antisense TS transfected cells. Interestingly, the transfection of antisense TS alone inhibited the cellular growth in vitro. The chemosensitivity to 5-FU was significantly increased in the transfected cells. The 50% inhibition values of 5-FU on DLD-1/anti-TS were approximately one forth that on parental cells. The augmentation of chemosensitivity to 5-FU was also confirmed in a nude mice model. The tumor growth of DLD-1/anti-TS cells was suppressed significantly more than that of DLD-1 cells by the 5-FU. The expression and activity of TS in human colon cancer cells were effectively inhibited by TS antisense treatment and the effect of 5-FU to cancer cells can be augmented. The antisense TS technology could be promising for treatments of gastrointestinal cancers.

UR - http://www.scopus.com/inward/record.url?scp=3843101696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843101696&partnerID=8YFLogxK

M3 - Article

C2 - 14654960

AN - SCOPUS:3843101696

VL - 24

SP - 217

EP - 222

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 1

ER -